Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults
- PMID: 14706660
- DOI: 10.1016/j.amjmed.2003.05.009
Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults
Abstract
Purpose: To determine the prevalence of hypertrophic cardiomyopathy in China.
Methods: This epidemiologic investigation was performed in 8080 adults from nine communities across nine provinces in China from October 2001 to February 2002, using a multistage, random sample design. Hypertrophic cardiomyopathy was defined as nondilated ventricular hypertrophy, documented by echocardiography, that was not caused by any known cardiac or systemic disease.
Results: Of the 4064 men and 4016 women who were screened, 13 (0.16%; 9 men and 4 women) had definite echocardiographic evidence for hypertrophic cardiomyopathy. The age- and sex-adjusted prevalence was about 80 per 100,000 adults.
Conclusion: Hypertrophic cardiomyopathy is not rare in China. Based on the estimated prevalence, there are at least 1 million cases in China.
Comment in
-
Hypertrophic cardiomyopathy: an important global disease.Am J Med. 2004 Jan 1;116(1):63-5. doi: 10.1016/j.amjmed.2003.10.012. Am J Med. 2004. PMID: 14706671 No abstract available.
Similar articles
-
Isolated right ventricular hypertrophic obstructive cardiomyopathy.J Assoc Physicians India. 1998 Nov;46(11):970-1. J Assoc Physicians India. 1998. PMID: 11229228
-
A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes.Cardiol Young. 2008 Dec;18(6):575-80. doi: 10.1017/S104795110800320X. Epub 2008 Oct 9. Cardiol Young. 2008. PMID: 18842161
-
Doppler echocardiography underestimates the prevalence and magnitude of mid-cavity obstruction in patients with symptomatic hypertrophic cardiomyopathy.Catheter Cardiovasc Interv. 2018 Mar 1;91(4):783-789. doi: 10.1002/ccd.27143. Epub 2017 Aug 2. Catheter Cardiovasc Interv. 2018. PMID: 28766836
-
Role of cardiac ultrasound in the assessment of hypertrophic cardiomyopathy.Int J Card Imaging. 1993;9 Suppl 2:51-3. doi: 10.1007/BF01143179. Int J Card Imaging. 1993. PMID: 8409553 Review.
-
Pathological and physiological left ventricular hypertrophy: echocardiography for differentiation.Future Cardiol. 2009 Sep;5(5):495-502. doi: 10.2217/fca.09.34. Future Cardiol. 2009. PMID: 19715413 Review.
Cited by
-
A retrospective clinical study of transaortic extended septal myectomy for obstructive hypertrophic cardiomyopathy in China.Eur J Cardiothorac Surg. 2013 Mar;43(3):534-40. doi: 10.1093/ejcts/ezs332. Epub 2012 Jul 3. Eur J Cardiothorac Surg. 2013. PMID: 22761504 Free PMC article.
-
Looking for hypertrophic cardiomyopathy in the community: why is it important?J Cardiovasc Transl Res. 2009 Dec;2(4):392-7. doi: 10.1007/s12265-009-9135-4. Epub 2009 Oct 20. J Cardiovasc Transl Res. 2009. PMID: 20559997 Review.
-
Clinical Characteristics for the Improvement of Cushing's Syndrome Complicated With Cardiomyopathy After Treatment With a Literature Review.Front Cardiovasc Med. 2021 Dec 1;8:777964. doi: 10.3389/fcvm.2021.777964. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34926625 Free PMC article.
-
Risk stratification in hypertrophic cardiomyopathy.Herz. 2020 Feb;45(1):50-64. doi: 10.1007/s00059-018-4700-8. Epub 2018 Apr 25. Herz. 2020. PMID: 29696341 Review. English.
-
The burden and management competency of cardiomyopathies in China: a nationwide survey study.Lancet Reg Health West Pac. 2024 Apr 11;46:101062. doi: 10.1016/j.lanwpc.2024.101062. eCollection 2024 May. Lancet Reg Health West Pac. 2024. PMID: 38623390 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical